In a July 28th release, Chr. Hansen Holding A/S announced the acquisition of UAS Laboratories located in Wausau, WI. In a transaction valued at $530 million.

UAS Laboratories was founded by Dr. S.K. Dash in 1979 and was originally located in Edina, MN.  The company produces probiotics based on Lactobacillus acidophilus DDS-1 strain.  Production capacity was expanded in 2012 and during the following year, UAS Laboratories was acquired by Lakeview Equity Partners. The company moved sales and marketing to Madison, WI. in January 2014.

Mauricio Graber, CEO of Chr. Hansen commented "with closing of the UAS Labs acquisition we look forward to building upon the strengths of both companies.  We will expand our probiotic offerings to gain access to new customer groups and move into new areas while staying true to our commitment to science and R&D”.

UAS Labs has 230 employees and is expected to generate revenue in 2020 approaching $85 million and an EBITDA above $30 million before synergy.  Chr. Hansen expects that by 2024 the acquisition will be accretive.